OpenAlex
PricingAboutJobs
Log inGet started
Work

PCSK9 inhibitors and cardiovascular outcomes

HTML

Year: 2019
Type: review
Source: Expert Opinion on Biological Therapy
DOI: 10.1080/14712598.2020.1677604
Authors: Daniel Steffens, Peter Bramlage, Céline Scheeff, Mario Kasner, Adel Hassanein, Julian Friebel, Ursula Rauch-Kröhnert
Institutions: Charité – Universitätsmedizin Berlin, IPPMed (Germany)
Language: English

Topic: Lipoproteins and Cardiovascular Health
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: PCSK9 inhibitors, evolocumab, alirocumab, LDL cholesterol lowering, atherosclerotic cardiovascular disease, acute coronary syndrome, statin therapy, ezetimibe, cardiovascular outcomes, lipid-lowering therapy, ODYSSEY OUTCOMES trial
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2979834087
FWCI: 0.615
Cites: 90
Cited by: 50
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security